Fredun Pharma Closes Trading Window for Q2 FY27 Results

Fredun Pharmaceuticals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from Wednesday, July 1st, 2026, until 48 hours after the board meeting where the unaudited financial results for the quarter ended June 30th, 2026, will be considered, approved, and declared. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.